Company Filing History:
Years Active: 2005-2007
Title: Thomas Dürig: Innovator in Extended Release Dosage Forms
Introduction
Thomas Dürig is an accomplished inventor based in Chadds Ford, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of extended release dosage forms. With a total of 2 patents to his name, Dürig continues to push the boundaries of innovation in drug delivery systems.
Latest Patents
Dürig's latest patents focus on amino acid modulated extended release dosage forms. The first patent discloses an oral extended release dosage form comprising a plurality of granules containing an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer. The granules are dispersed within a hydrophilic extragranular polymer matrix that hydrates more rapidly than the intragranular polymer. The selection of amino acids is based on their hydropathy characteristics, which depend on the solubility characteristics of the active compound. This innovative approach enhances the effectiveness of drug delivery.
Career Highlights
Dürig is currently associated with Scolr, Inc., where he applies his expertise in pharmaceutical formulations. His work has been instrumental in advancing the science of drug delivery, making medications more effective and patient-friendly.
Collaborations
Dürig collaborates with A Reza Fassihi, a fellow innovator in the field. Their combined efforts contribute to the development of cutting-edge pharmaceutical technologies.
Conclusion
Thomas Dürig is a notable inventor whose work in extended release dosage forms is paving the way for advancements in pharmaceutical science. His innovative patents and collaborations reflect his commitment to improving drug delivery systems.